hsa-miR-301a

ncRNA information

ncRNA name

hsa-miR-301a

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

TCEAL7

Cancer information

Cancer name

Glioma

Cancer site

Brain, Central Nervous System

Treatment information

Treatment type

Radiotherapy

Impact of wild-type ncRNA on radiotherapy resistance

Up

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Here we show that exomiR-301a, which is characteristically expressed and secreted by hypoxic glioma cells, is a potent regulator of Wnt/b-catenin and then depresses radiation sensitivity through targeting anti-oncogene TCEAL7.

Tissue resource

pilocyticastrocytomas,diffuse astrocytomas,anaplasia astrocytomas and primary GBMs

Experiment

Luciferase reporter assay


Institute

the Affiliated Hospital of Xiangnan University, the National Cancer Center/Cancer Hospital & Shenzhen Hospital, the PLA Airforce General Hospital

Country

China

Continent

Asia